In cancer stem cells, studies have shown that the depletion of FTO and ALKBH5 leads to increased m6A modification, which can significantly reduce the self-renewal ability of cancer stem cells (Zhang et al., 2017; Su et al., 2020). The gene discussed is FTO; the disease is cancer.